Previous 10 | Next 10 |
NeuroOne® Medical Technologies Corporation Releases Successful Long-Term Recording Test Data for its Novel Thin Film Platform Electrode Technology Successful results of 5-year test data opens potential opportunity for long-term recording applications for Parkinson's disease...
Today there is a massive $13.6 billion neurostimulation devices market developing for the ongoing study of the vast arrays of the brain’s neural connections. (1) The diagnostic electrode technology currently used to detect neurological disorders is the same that was developed way back ...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
NeuroOne to Host First Quarter Fiscal Year 2022 Earnings Call PR Newswire EDEN PRAIRIE, Minn. , Feb. 2, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on impro...
RALEIGH, NC / ACCESSWIRE / January 28, 2022 / The Winter Wonderland Best Ideas Virtual Investor Conference will take place on February 8 th - 11 th , 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience. The vir...
NeuroOne Appoints Chad Wilhelmy, as Vice President of Quality Control and Regulatory Affairs PR Newswire EDEN PRAIRIE, Minn. , Jan. 18, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical tec...
NeuroOne Featured on The Medical Alley Podcast: "A Conversation with Dave Rosa, President and CEO, NeuroOne" PR Newswire EDEN PRAIRIE, Minn. , Dec. 20, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a ...
NeuroOne Medical Technologies Corporation (NMTC) Q4 2021 Earnings Conference Call Dec 15, 2021 09:00 AM ET Company Participants James Carbonara - Hayden IR Dave Rosa - Chief Executive Officer Ron Mcclurg - Chief Financial Officer Conference Call Participants Alex Knopick - Craig-Hallum Capita...
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC): Q4 Net loss of $2.6M Revenue of $0.05M beats by $0.02M. Press Release Shares +12.07% PM For further details see: NeuroOne Medical Technologies Corporation beats on revenue
NeuroOne Reports Fourth Fiscal Quarter and Full Fiscal Year 2021 Financial Results and Provides Corporate Update PR Newswire EDEN PRAIRIE, Minn. , Dec. 15, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC; "NeuroOne" or the "Compa...
News, Short Squeeze, Breakout and More Instantly...
NeuroOne Medical Technologies Corporation Company Name:
NMTC Stock Symbol:
NASDAQ Market:
NeuroOne Medical Technologies Corporation Website:
Five ablations performed successfully in one patient Procedure performed at patient’s bedside saving time and cost associated with the operating room EDEN PRAIRIE, Minn., June 25, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ( ...